Home > Publications Database > A protocol for isolation and enriched monolayer cultivation of neural precursor cells from mouse dentate gyrus. > print

001     135985
005     20240321220008.0
024 7 _ |a 10.3389/fnins.2011.00089
|2 doi
024 7 _ |a pmid:21811434
|2 pmid
024 7 _ |a pmc:PMC3140691
|2 pmc
024 7 _ |a 1662-453X
|2 ISSN
024 7 _ |a 1662-4548
|2 ISSN
037 _ _ |a DZNE-2020-02307
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Babu, Harish
|0 P:(DE-HGF)0
|b 0
245 _ _ |a A protocol for isolation and enriched monolayer cultivation of neural precursor cells from mouse dentate gyrus.
260 _ _ |a Lausanne
|c 2011
|b Frontiers Research Foundation
264 _ 1 |3 online
|2 Crossref
|b Frontiers Media SA
|c 2011-01-01
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1603722116_26064
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a In vitro assays are valuable tools to study the characteristics of adult neural precursor cells under controlled conditions with a defined set of parameters. We here present a detailed protocol based on our previous original publication (Babu et al., 2007) to isolate neural precursor cells from the hippocampus of adult mice and maintain and propagate them as adherent monolayer cultures. The strategy is based on the use of Percoll density gradient centrifugation to enrich precursor cells from the micro-dissected dentate gyrus. Based on the expression of Nestin and Sox2, a culture-purity of more than 98% can be achieved. The cultures are expanded under serum-free conditions in Neurobasal A medium with addition of the mitogens Epidermal growth factor and Fibroblast growth factor 2 as well as the supplements Glutamax-1 and B27. Under differentiation conditions, the precursor cells reliably generate approximately 30% neurons with appropriate morphological, molecular, and electrophysiological characteristics that might reflect granule cell properties as their in vivo counterpart. We also highlight potential modifications to the protocol.
536 _ _ |a 342 - Disease Mechanisms and Model Systems (POF3-342)
|0 G:(DE-HGF)POF3-342
|c POF3-342
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Claasen, Jan-Hendrik
|0 P:(DE-2719)9000049
|b 1
700 1 _ |a Kannan, Suresh
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Rünker, Annette E
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Palmer, Theo
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Kempermann, Gerd
|0 P:(DE-2719)2000011
|b 5
|e Last author
|u dzne
773 1 8 |a 10.3389/fnins.2011.00089
|b : Frontiers Media SA, 2011-01-01
|3 journal-article
|2 Crossref
|t Frontiers in Neuroscience
|v 5
|y 2011
|x 1662-4548
773 _ _ |a 10.3389/fnins.2011.00089
|g Vol. 5
|0 PERI:(DE-600)2411902-7
|q 5
|p 89
|t Frontiers in neuroscience
|v 5
|y 2011
|x 1662-4548
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/135985/files/fnins-05-00089.pdf
856 4 _ |y OpenAccess
|x icon
|u https://pub.dzne.de/record/135985/files/fnins-05-00089.gif?subformat=icon
856 4 _ |y OpenAccess
|x icon-1440
|u https://pub.dzne.de/record/135985/files/fnins-05-00089.jpg?subformat=icon-1440
856 4 _ |y OpenAccess
|x icon-180
|u https://pub.dzne.de/record/135985/files/fnins-05-00089.jpg?subformat=icon-180
856 4 _ |y OpenAccess
|x icon-640
|u https://pub.dzne.de/record/135985/files/fnins-05-00089.jpg?subformat=icon-640
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/135985/files/fnins-05-00089.pdf?subformat=pdfa
856 7 _ |2 Pubmed Central
|u http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140691
909 C O |o oai:pub.dzne.de:135985
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 1
|6 P:(DE-2719)9000049
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 5
|6 P:(DE-2719)2000011
913 1 _ |a DE-HGF
|b Forschungsbereich Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-342
|2 G:(DE-HGF)POF3-300
|v Disease Mechanisms and Model Systems
|x 0
914 1 _ |y 2011
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b FRONT NEUROSCI-SWITZ : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Blind peer review
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
920 1 _ |0 I:(DE-2719)1710001
|k AG Kempermann 1
|l Adult Neurogenesis
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1710001
980 1 _ |a FullTexts

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21